152 - Substance induced anxiety disorders

Substance-induced anxiety disorders

493 Disorders due to substance use or addictive behaviours Substance-induced mood disorder with mixed depressive and manic symptoms • All diagnostic requirements for substance-induced mood disorder are met. • The presentation is characterized by both depressive and manic symptoms judged to be the direct consequence of the use of or withdrawal from a specified substance or medication. Substance-induced mood disorder, unspecified Substance-induced anxiety disorders Available categories by substance class 6C40.71 Alcohol-induced anxiety disorder 6C41.71 Cannabis-induced anxiety disorder 6C42.71 Synthetic cannabinoid-induced anxiety disorder 6C43.71 Opioid-induced anxiety disorder 6C44.71 Sedative, hypnotic or anxiolytic-induced anxiety disorder 6C45.71 Cocaine-induced anxiety disorder 6C46.71 Stimulant-induced anxiety disorder, including amfetamines, methamfetamine and methcathinone 6C47.71 Synthetic cathinone-induced anxiety disorder 6C48.40 Caffeine-induced anxiety disorder 6C49.61 Hallucinogen-induced anxiety disorder 6C4B.71 Volatile inhalant-induced anxiety disorder 6C4C.71 MDMA or related drug-induced anxiety disorder, including MDA 6C4D.61 Dissociative-induced anxiety disorder, including ketamine and PCP 6C4E.71 Anxiety disorder induced by other specified psychoactive substance 6C4F.71 Anxiety disorder induced by multiple specified psychoactive substances 6C4G.71 Anxiety disorder induced by unknown or unspecified psychoactive substances Essential (required) features • The presentation is characterized by anxiety symptoms (e.g. apprehension or worry, fear, physiological symptoms of excessive autonomic arousal, panic attacks, avoidance behaviour) that develop during or soon after intoxication with or withdrawal from a specified substance, or use or discontinuation of a psychoactive medication. • The intensity or duration of the anxiety symptoms is substantially in excess of anxiety symptoms that are characteristic of intoxication or withdrawal due to the specified substance. • The specified substance, as well as the amount and duration of its use, is known to be capable of producing anxiety symptoms (see the list above and Table 6.14, p. 454). • The symptoms are not better accounted for by another mental disorder such as an anxiety or fear-related disorder, a depressive disorder with prominent anxiety symptoms, or posttraumatic stress disorder. Evidence supporting a diagnosis of another mental disorder 6C4x.y02 6C4x.y0Z Substance-induced anxiety disorders